Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Spink Katharine E.
 2. Date of Event Requiring Statement (Month/Day/Year)
02/25/2009		 3. Issuer Name and Ticker or Trading Symbol
GERON CORP [GERN]
(Last)
(First)
(Middle)
C/O GERON CORPORATION, 230 CONSTITUTION DRIVE		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
VP Ops, Regen Med Programs
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

MENLO PARK, CA 94025		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 6,406 (1)
D
 
Common Stock 2,625 (2)
D
 
Common Stock 4,375 (3)
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) 12/17/2007 12/17/2013 Common Stock 30,000 $ 10.01 D  
Stock Option (right to buy) 05/27/2008 05/27/2014 Common Stock 4,849 $ 7.56 D  
Stock Option (right to buy)   (4) 05/06/2015 Common Stock 12,000 $ 6.4 D  
Stock Option (right to buy)   (5) 05/24/2016 Common Stock 13,130 $ 6.63 D  
Stock Option (right to buy)   (6) 05/23/2017 Common Stock 7,000 $ 9.32 D  
Stock Option (right to buy)   (7) 05/28/2018 Common Stock 8,750 $ 3.97 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Spink Katharine E.
C/O GERON CORPORATION
230 CONSTITUTION DRIVE
MENLO PARK, CA 94025		       VP Ops, Regen Med Programs  

Signatures

/s/ Olivia Bloom for Katharine E. Spink 02/26/2009
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The shares of restricted stock will remain subject to a repurchase right of Geron until May 23, 2009, at which time such repurchase right will lapse. The lapse of Geron's repurchase right is conditioned on the employee continuing to provide services to the Company through the vesting date.
(2) The shares of restricted stock will remain subject to a repurchase right of Geron over four years, commencing May 23, 2007, during such time the repurchase right will lapse with respect to 25% of such shares on each anniversary date of the date of grant. The lapse of Geron's repurchase right is conditioned on the employee continuing to provide services to the Company through each vesting date.
(3) The shares of restricted stock will remain subject to a repurchase right of Geron over four years, commencing May 28, 2008, during such time the repurchase right will lapse with respect to 25% of such shares on each anniversary date of the date of grant. The lapse of Geron's repurchase right is conditioned on the employee continuing to provide services to the Company through each vesting date.
(4) This option is exercisable in a series of 48 equal monthly installments commencing May 6, 2005 provided the optionee continues to provide services to the Company.
(5) This option is exercisable in a series of 48 equal monthly installments commencing May 24, 2006 provided the optionee continues to provide services to the Company.
(6) This option is exercisable in a series of 48 equal monthly installments commencing May 23, 2007 provided the optionee continues to provide services to the Company.
(7) This option is exercisable in a series of 48 equal monthly installments commencing May 28, 2008 provided the optionee continues to provide services to the Company.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.